Results 21 to 30 of about 4,306 (252)

Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis. [PDF]

J Clin Med, 2021
Hikal M, Celik N, Auffarth GU, Kessler LJ, Mayer CS, Khoramnia R.   +5 more
europepmc   +3 more sources

Keratoprosthesis, silicone oil placement, and fluocinolone acetonide implant for treatment of uveitis-associated hypotony and keratopathy. [PDF]

J Ophthalmic Inflamm Infect, 2022
Mosenia A, Sundararajan M, Stewart JM, Schallhorn JM.   +3 more
europepmc   +3 more sources

A Meta-Analysis of the Efficacy and Safety of the 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis. [PDF]

Biomedicines
Yeo S, Chung YR, Song JH, Bodaghi B, Touhami S.   +4 more
europepmc   +2 more sources

Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]

J Ophthalmic Inflamm Infect
Pleyer U, Pavesio C, Miserocchi E, Heinz C, Devonport H, Llorenç V, Burke T, Nogueira V, Kodjikian L, Bodaghi B.   +9 more
europepmc   +2 more sources

Cost-Effectiveness Analysis of Fluocinolone Acetonide Intravitreal (FAI) Implant for Chronic Noninfectious Uveitis Affecting the Posterior Segment of the Eye (NIU-PS) in China. [PDF]

Ophthalmol Ther
Mao X, Dai Z, Yang J, Wu Y, Xie F, Lu Y, Yu J, Chang F, Lu Y.   +8 more
europepmc   +2 more sources

Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network. [PDF]

J Pers Med
Jabbour M, Kodjikian L, Bourdin A, Rougier MB, Serrar Y, Weber M, Massé H, Mazhar D, Perez-Roustit S, Chiquet C, Delyfer MN, Bodaghi B, Touhami S.   +12 more
europepmc   +3 more sources

Mass spectrometry in ocular drug research

Mass Spectrometry Reviews, EarlyView., 2023
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo, Kati‐Sisko Vellonen, Arto Urtti, Tetsuya Terasaki, Anam Hammid, Paavo Honkakoski, Seppo Auriola   +6 more
wiley   +1 more source

Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases [PDF]

, 2023
Purpose For the treatment of macular edema, in addition to the use of antivascular endothelial growth factors, steroids are also used intravitreally and sub-Tenon.
Abdin, Alaa Din, Löw, Ursula, Munteanu, Cristian, Seitz, Berthold, Wykrota, Agata Anna   +4 more
core   +1 more source

Synthesis and RP-TLC lipophilicity evaluation of a novel fluocinolon acetonide soft drug derivative [PDF]

Kragujevac Journal of Science, 2016
Cortienic acid was obtained by periodic acid oxidation of fluocinolone acetonide, whereas corresponding amide was synthesized from the cortienic acid and ethyl ester of b-alanine by dicyclohexylcarbodiimide - hydroxybenzotriazole coupling procedure ...
Dobričić Vladimir, Vladimirov Sote, Čudina Olivera   +2 more
doaj   +1 more source

Clinical-decision criteria to identify recurrent diabetic macular edema patients suitable for fluocinolone acetonide implant therapy (Iluvien®) and follow-up considerations/ recommendations [PDF]

, 2020
Current management of diabetic macular edema (DME) predominantly involves treatment with short-acting intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) and/or corticosteroids; however, short-acting therapies (lasting ...
Abraldes, M., Adán, A., Armadá, F., Ascaso, F.J., Cabrera, F., Cervera, E., Figueroa, M.S., Pazos, M., Pessoa, B., Reyes, M.Á., Udaondo, P.   +10 more
core   +3 more sources